Login

Mangold Insight interviews tech company DLTx, delving into discussions on AI competitiveness with a reference to C3.ai. 00:10:00

Share On Facebook Share On Twitter

DLTx's founder is Timothy Furey.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Eradicate homelessness through design and technology|Anurag Srivastava,Founding Partner,Jungle Ventures
00:10:00
Chris Flowers on Financial Crises: Reflections and Future Risks | Chris Flowers, CEO, J.C. Flowers & Co.
00:10:00
Teemu Suna on Revolutionizing Global Healthcare with Nightingale Health | Teemu Suna, CEO , Nightingale Health Oyj.
00:10:00
Path to Retirement: Reaching and Relishing Your Golden Years | Matthew Kelley - President of Gold Medal Waters, Inc.
00:10:00
King Cora Copper's Exploration Ambitions in Mongolia: Insights from CEO Sam Spring at the One-to-One Conference
00:10:00
Thomas Arnoldner, CEO of A1 Telekom Austria Group, discusses the value of diversity and inclusion in business during the myAbility CxO-Talk.
00:10:00
Macro Risks: Insights Live on Finding Relative Value with Wayne Dahl, Madelaine Jones, and David Rosenberg
00:10:00
Nuveen is a global investment leader, managing an array of public and private assets for clients around the world and on behalf of our parent company TIAA , one of the world’s largest institutional investors,1 a highly-rated2 insurance company and a retir
00:10:00
Fury Gold Mines: From Turnaround Success to Growth in Nevada
00:10:00
Catalyst Metals Revitalizes WA Gold Belt and Expands Bendigo Goldfield Exploration
00:10:00
Iran's Nuclear Ambitions and Regional Strategy: An Analysis by Victor Davis Hanson and Robert Baer|
00:10:00
Inca One Gold Closes $500K Private Placement with OSUM

© 2026 Nehu